login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ADVERUM BIOTECHNOLOGIES INC (ADVM) Stock News
USA
-
Nasdaq
- NASDAQ:ADVM -
US00773U2078
-
Common Stock
4.12
USD
-0.04 (-0.96%)
Last: 11/28/2025, 8:11:44 PM
4.1472
USD
+0.03 (+0.66%)
After Hours:
11/28/2025, 8:11:44 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ADVM Latest News, Press Relases and Analysis
All
Press Releases
10 days ago - By: Zacks Investment Research
- Mentions:
LLY
JNJ
ABBV
Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales
11 days ago - By: Halper Sadeh LLC
- Mentions:
CMA
HOUS
Halper Sadeh LLC Encourages CMA, ADVM, HOUS Shareholders to Contact the Firm to Discuss Their Rights
12 days ago - By: Zacks Investment Research
- Mentions:
LLY
JNJ
The Zacks Analyst Blog Highlights Eli Lilly, Johnson & Johnson and Adverum
13 days ago - By: Benzinga
- Mentions:
APOG
COCO
HPQ
YUM
...
This Yum! Brands Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
a month ago - By: Stocktwits
- Mentions:
LLY
Eli Lilly To Acquire Adverum Biotechnologies
a month ago - By: Eli Lilly and Company
- Mentions:
LLY
Lilly to Acquire Adverum Biotechnologies
13 days ago - By: Benzinga
- Mentions:
COCO
MASI
HPQ
TATT
...
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
13 days ago - By: Zacks Investment Research
- Mentions:
LLY
JNJ
NVO
Growth or Stability? A 2025 Investment Face-Off Between LLY and JNJ
18 days ago - By: Zacks Investment Research
- Mentions:
LLY
NVO
VKTX
Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock?
a month ago - By: Zacks Investment Research
- Mentions:
NVO
LLY
Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales
a month ago - By: Halper Sadeh LLC
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders
a month ago - By: Kahn Swick & Foti, LLC
Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM
a month ago - By: Halper Sadeh LLC
- Mentions:
MOFG
HSII
Halper Sadeh LLC Encourages ADVM, MOFG, HSII Shareholders to Contact the Firm to Discuss Their Rights
a month ago - By: Ademi LLP
Shareholder Alert: The Ademi Firm investigates whether Adverum Biotechnologies, Inc. is obtaining a Fair Price for its Public Shareholders
a month ago - By: Halper Sadeh LLC
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. is Fair to Shareholders
a month ago - By: Bloomberg
- Mentions:
LLY
Lilly to Buy Eye Gene Therapy Company Adverum Biotechnologies
3 months ago - By: Adverum Biotechnologies, Inc.
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 months ago - By: Adverum Biotechnologies, Inc.
Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights
4 months ago - By: Adverum Biotechnologies, Inc.
Adverum Biotechnologies to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
6 months ago - By: Adverum Biotechnologies, Inc.
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
7 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
7 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
7 months ago - By: Adverum Biotechnologies, Inc.
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
7 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
7 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
7 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
7 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
8 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
8 months ago - By: Adverum Biotechnologies, Inc.
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones
Please enable JavaScript to continue using this application.